T 0764/06 (Crystalline form of atorvastatin/WARNER-LAMBERT COMPANY LLC) of 25.2.2009

European Case Law Identifier: ECLI:EP:BA:2009:T076406.20090225
Date of decision: 25 February 2009
Case number: T 0764/06
Petition for review: R 0016/09
Application number: 96924368.2
IPC class: C07D 207/34
Language of proceedings: EN
Distribution: C
Download and more information:
Decision text in EN (PDF, 116 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Crystalline R-(R*,R*)-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-(phenylamino)carbonyl-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
Applicant name: Warner-Lambert Company LLC
Opponent name: Teva Pharmaceutical Industries Ltd.
LEK Pharmaceutical and Chemical Company d.d.
Board: 3.3.01
Headnote: -
Relevant legal provisions:
European Patent Convention Art 123(2)
European Patent Convention 1973 Art 114(2)
European Patent Convention 1973 Art 113(1)
European Patent Convention 1973 Art 100(c)
Rules of procedure of the Boards of Appeal Art 13(1)
Rules of procedure of the Boards of Appeal Art 13(3)
European Patent Convention 1973 R 55(c)
European Patent Convention R 76(c)
Keywords: Admissibility of allegedly new ground of opposition (yes)
Added matter (yes) - Omission of an essential feature
Late-filed request (not admitted)
Catchwords:

-

Cited decisions:
G 0009/91
G 0010/91
G 0001/95
G 0007/95
T 0737/92
T 0926/93
T 0114/95
T 1180/97
T 0128/98
T 0746/99
Citing decisions:
R 0007/14
T 2016/11

15 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

EPC Implementing Rules

Case Law Book: IV Divisional Applications

Case Law of the Enlarged Board

General Case Law